WGS genedx.com Company Short-Term Debt

Official company branding of genedx.com (WGS)

Bio-espionage risks and government bans on the cross-border transfer of DNA data are constraining the global growth of GeneDx Holdings Corp. (WGS). A breakdown of short-term debt helps assess the business's solvency and liquidity, with the current figure standing at 0.00. GeneDx Holdings Corp. (WGS) dominates sequencing through AI algorithms and the largest exome database, steadily moving toward operating profit via pediatric diagnostics, which remain independent of macroeconomic trends.

WGS (genedx.com) Short-Term Debt history from 04/28/2023 to 11/01/2026

Financial and market metric breakdowns for GeneDx Corp (WGS)

- stock price and consensus target price:
Stock Price GeneDx|WGS - Average Forecast Price
- market capitalization data:
Market Value GeneDx Holdings|WGS - Business Value
- shareholders' equity book value data:
Book Value per Share GeneDx|WGS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio genedx.com|WGS - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio GeneDx Holdings Corp.|WGS - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio GeneDx Holdings Corp.|WGS - Aggregate Debt Obligations|Debts to Book Capitalization GeneDx Holdings|WGS - Company Long-Term Loans and Borrowings|Company Short-Term Debt GeneDx|Quick Liquidity genedx.com
- net income and valuation multiples indicators:
WGS - Company Net Income
General company analysis:GeneDx (WGS)
Flagship merchandise of genedx.com

Investors in GeneDx Holdings Corp. (WGS) are balancing market capitalization growth potential against liquidity risks driven by debt servicing. An analysis of current short-term liabilities allows for an assessment of the mathematical precision of daily debt calculations, which, combined with the unique WGS genome database, determine the company's ability to withstand competitive pressure and fund high-precision diagnostics without a critical increase in interest expenses.

Competing companies

Tempus AI, Inc - Company Short-Term Debts|Short-Term Debt Qiagen NV|Ionis Pharma (IONS) - Company Short-Term Debt|Company Short-Term Indebtedness RGEN|RNA (Avidity Biosciences) - Company Short-Term Debts|Short-Term Debt crisprtx.com CRSP|Company Short-Term Debts RARE|Beam Therapeutics Inc - Company Short-Term Indebtedness|Sarepta Therapeutics Inc - Company Current Liabilities|TWST: Company Short-Term Indebtedness|TXG: Company Current Liabilities|Company Short-Term Loans and Borrowings NTLA (intelliatx.com)|STOK: Company Short-Term Debts|BioLife Solutions Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt Wave Life Sciences Corp|Short-Term Debt Maze Therapeutics Corp MAZE|Company Short-Term Debt Sionna Therapeutics Inc (SION)|Company Short-Term Debt PRME (primemedicine.com)|Company Short-Term Debts TSHA (Taysha Gene Therapies, Inc.)|QURE: Company Short-Term Indebtedness|MeiraGTx PLC - Company Short-Term Debts|Short-Term Debt Volume REGENXBIO Corp RGNX|Solid Biosciences Inc. (SLDB) - Company Short-Term Debt|Company Short-Term Indebtedness OCGN|PACB (PacBio) - Company Short-Term Debts|BNTC - Short-Term Indebtedness|Company Short-Term Debt Design Pharma (DSGN)|Short-Term Debt Volume Rocket Corp|4D Molecular Therapeutics - Company Current Liabilities|Company Short-Term Loans and Borrowings LXEO|Korro Bio, Inc - Company Short-Term Debts|Editas Medicine Inc (EDIT) - Company Current Liabilities|Silence Therapeutics Inc. (SLN) - Company Short-Term Debt|Short-Term Debt ProQR Therapeutics (PRQR)|Company Short-Term Debt Codexis Inc|SGMO: Company Short-Term Loans and Borrowings|Company Short-Term Debt Nautilus Biotechnology (NAUT)|MGX: Current Liabilities|Precision BioSciences - Company Current Liabilities|Short-Term Debt Volume Generation Bio Co (GBIO)|BOLD: Company Current Liabilities|Exicure, Inc. (XCUR) - Company Current Liabilities|IMNN: Company Short-Term Debts|Short-Term Indebtedness Phio Pharmaceuticals Corp. PHIO|Company Short-Term Debt Mustang Bio Inc|TransCode (RNAZ) - Short-Term Debt Volume|Company Short-Term Debts BNGO|adnas.com - Company Short-Term Indebtedness|Company Short-Term Debt bluebird bio BLUE|IPA: Company Short-Term Indebtedness|Omega - Company Short-Term Debts|OMIC - Company Short-Term Debts|RGLS: Company Short-Term Debts|Short-Term Indebtedness syros.com SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Short-Term Debt TRACON Pharmaceuticals Inc. TCON|Company Short-Term Debt Unity Bio (UBX)